APA (7th ed.) Citation

R, N., J, D., M, A. M., T, Z. I., RJ, O., A, T., . . . GD, S. (2025). Serotonin-norepinephrine reuptake inhibitor and gabapentinoid use independently predict greater postoperative opioid consumption in lumbar fusion patients. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 34(6), 2445. https://doi.org/10.1007/s00586-025-08764-6

Chicago Style (17th ed.) Citation

R, Narayanan, et al. "Serotonin-norepinephrine Reuptake Inhibitor and Gabapentinoid Use Independently Predict Greater Postoperative Opioid Consumption in Lumbar Fusion Patients." European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 34, no. 6 (2025): 2445. https://doi.org/10.1007/s00586-025-08764-6.

MLA (9th ed.) Citation

R, Narayanan, et al. "Serotonin-norepinephrine Reuptake Inhibitor and Gabapentinoid Use Independently Predict Greater Postoperative Opioid Consumption in Lumbar Fusion Patients." European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, vol. 34, no. 6, 2025, p. 2445, https://doi.org/10.1007/s00586-025-08764-6.